The PK and PD of dapagliflozin therapy in combination with insulin in Japanese subjects with T1DM

Trial Identifier: D1695C00001sub
Sponsor: AstraZeneca
NCTID:: NCT02582840
Start Date: October 2015
Primary Completion Date: June 2016
Study Completion Date: June 2016
Condition: Diabetes: Type 1

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Japanese Translation

Trial Locations

Country Location
Japan Fukuoka-shi, Japan